openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of CV Sciences, Inc. (OTC: CVSI)

02-04-2020 10:58 PM CET | Politics, Law & Society

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in CV Sciences, Inc. (OTC: CVSI) shares.

An investigation on behalf of current long term investors in CV Sciences, Inc. (OTC: CVSI) shares.

An investigation on behalf of current long-term investors in shares of CV Sciences, Inc. (OTC: CVSI) concerning potential breaches of fiduciary duties by certain directors and officers of CV Sciences, Inc. was announced.

Investors who are current long term investors in CV Sciences, Inc. (OTC: CVSI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in CV Sciences, Inc. (OTC: CVSI stocks follows a lawsuit filed against CV Sciences, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in OTC: CVSI stocks, concerns whether certain CV Sciences, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Nevada the plaintiff alleges that the Defendants failed to disclose that its Patent #15/426,617 received a non-final rejection from the USPTO on April 27, 2017, that a final rejection from the USPTO on December 14, 2017, and that as a result of the foregoing, Defendants' statements about CV Sciences' business, operations, and prospects, were materially false and/or misleading and/or lacked a reasonable basis.

Those who purchased shares of CV Sciences, Inc. (OTC: CVSI) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of CV Sciences, Inc. (OTC: CVSI) here

News-ID: 1919161 • Views: 406

More Releases from Shareholders Foundation

Investigation announced for Investors in NYSE: NOVA shares over potential Wrongd …
An investigation on behalf of investors in shares of Sunnova Energy International Inc. (NYSE: NOVA) was announced over potential breaches of fiduciary duties by certain officers and directors at Sunnova Energy International Inc. Investors who purchased shares of Sunnova Energy International Inc. (NYSE: NOVA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Sunnova Energy
Investigation for Investors in E*TRADE Financial Corporation (NASDAQ: ETFC) over …
An investigation was announced concerning whether the takeover of E*TRADE Financial Corporation is unfair to NASDAQ: ETFC stockholders. Investors who purchased shares of E*TRADE Financial Corporation (NASDAQ: ETFC) and currently hold any of those NASDAQ: ETFC shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of E*TRADE Financial Corporation breached their
Investigation announced for Long Term Investors in shares of Altria Group, Inc. …
Certain directors of Altria Group, Inc are under investigation concerning potential breaches of fiduciary duties. Investors who are current long term investors in Altria Group, Inc. (NYSE: MO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for investors in NYSE: MO stocks follows a lawsuit filed against Altria Group, Inc. over alleged securities laws violations.
Investigation announced for Long-Term Investors in NASDAQ: MDXG shares over poss …
An investigation was announced concerning possible breaches of fiduciary duties by certain directors at MiMedx Group Inc. Investors who purchased shares of MiMedx Group Inc (NASDAQ: MDXG) and currently hold any of those NASDAQ: MDXG shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain MiMedx Group directors breached their fiduciary duties and caused damage

All 5 Releases


More Releases for Sciences

Conference on Nutrition and Food Sciences
ConferenceSeries LLC Ltd is overwhelmed to announce the commencement of the 22nd World Congress on Nutrition & Food Sciences, which is to be held during June 17-18, 2019 in Brisbane, Australia. This Nutrition assembly point awesomely emphasis on Nutrition & Food Sciences - Fundamentals of a Healthy Life. Contact: nutritionasia@nutritionalconference.com Conference Series LLC LTD is an open resource platform that conducts 3000+ global events including International Conferences, Workshops, Symposia, Trade Shows, Exhibitions and
BOC Sciences Launched Impurities for Scientific Research
BOC Sciences, headquartered in Shirley, New York, announced that a rich collection of impurities are now available for scientific research use on July 27, 2018. In the process of drug development and manufacturing, profiling and controlling impurities level is of considerable importance as their side pharmaceutical effects may affect the efficacy and safety of active pharmaceutical ingredients (APIs). In most cases, an exceeding amount of impurity level would lead
Bayer Crop Sciences Ltd
Bayer Crop Sciences Ltd Bayer Crop Sciences Ltd- Company Profile & Financial Analysis” contains in depth information and data about the company and its operations. You will find information on the business structure, areas of operation, products and services offered by the company. It also comprises SWOT analysis, key ratios, historical financial data and insider’s view on financial stability and industrial ranking with financial forecasts for two- year period. This report is
Gallene Sciences, promoting health and well-being.
Gallene Sciences’ strategy emphasises three key areas: -Health: Gallene science manufactures and distributes affordable high- quality generic medicines, complying with regulatory standards for manufacturing, health and safety. Through its range of pharma- ceuticals, Gallene Sciences laboratory treats a wide number [well known] viruses and chronic It lends its expertise to providing high- quality but affordable therapies for HIV / AIDS. It also contributes to the treatment of viral hepatitis, diabetes or and hypertension. Research: Gallene Sciences’ research center
Global Life Sciences BPO Market
The Global Life Sciences BPO Market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights.Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO). Request Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/24 Increasing demand for low cost
Global life sciences BPO market
TheGlobal life sciences BPO market was valued US$ 180.4 billion in 2015 and is projected to reach US$ 505.0 billion by 2024, according to a new report published by Coherent Market Insights.Reducing cost and increasing focus on core strengths is influencing medical device and pharmaceutical companies to outsource their processes to contract manufacturing organizations (CMO) and contract research organizations (CRO). Request Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/24 Increasing demand for low cost drugs,